FDA Okays Combination Gel for Mild-to-Moderate Acne
Posted on January 13, 2009
FORT WORTH, Tex., Jan. 6 — For mild-to-moderate acne in patients 12 and older, the FDA has approved a once-a-day gel that combines adapalene and benzoyl peroxide gel (Epiduo Gel 0.1%, 2.5%), the drug maker announced.
According to Galderma, the combination gel “treats both inflammatory and non-inflammatory lesions with no evidence of promoting antibiotic resistance, simplifying the management of mild-to-moderate acne.”
The approval followed a 517-patient phase II trial published last year in the Journal of the American Academy of Dermatology that found the gel reduced the median number of total acne lesions by more than 50% by the end of the 12-week study.
Tags: Acne, Combination, Mild-to-Moderate, Okays
